ClinConnect ClinConnect Logo
Search / Trial NCT07033390

Monitor Orthopaedic Footwear Questionnaire (MOS) Validity and Reliability Study

Launched by MEDIPOL UNIVERSITY · Jun 13, 2025

Trial Information

Current as of November 08, 2025

Enrolling by invitation

Keywords

Validity Reability Orthopedic Shoes Survey

ClinConnect Summary

This study is about translating the Monitor Orthopaedic Shoes Questionnaire (MOS) into Turkish (called MOS-T) and testing whether the Turkish version is both valid (it measures what it’s supposed to) and reliable (it produces consistent results). It’s an observational study, meaning researchers will observe and collect survey data rather than test a treatment. About 200 people who use orthopedic shoes are being invited to participate. Eligible participants are aged 16 to 75, native Turkish speakers who can read and fill out the survey, are wearing orthopedic shoes for the first time, and can complete the questionnaire without help. The work is taking place at Istanbul Medipol University in Istanbul.

If you join, you’ll complete the MOS-T questionnaire once, and then redo it about 8 weeks later to see if responses stay stable over time. The researchers will use standard statistics to check that MOS-T matches the original questionnaire and works consistently. This study is overseen by a monitoring committee and is not a drug or device trial. Enrollment is ongoing by invitation, with start around June 30, 2025 and an estimated finish around November 30, 2025. Results will be shared later, but individual results are not yet available.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Wearing orthopedic shoes for the first time,
  • Being 16 years old and above,
  • Being a native Turkish speaker and having at least a literacy level,
  • Being able to complete the survey without assistance regarding cognitive or physical disorders,
  • Volunteering to participate in the study

About Medipol University

Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.

Locations

Beykoz, Istanbul, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported